HHealth Read More New HIV Pill Delivers Breakthrough Results In First Human TrialAugust 1, 2026 A promising new HIV treatment has passed its first test in people, giving researchers hope for another effective…
MMedication Read More Lilly’s Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapyJune 26, 2026 The positive opinion is based on results from the Phase 3 BRUIN CLL-313 and BRUIN CLL-314 trials, previously…
MMedication Read More New Baldness Pill Boosts Hair Coverage by Up to 86% in Six MonthsJune 25, 2026 AI-generated image. A familiar hair-loss drug may be getting a major upgrade. A slow-release formulation of minoxidil, one…
MMedication Read More Do GLP-1 pills work as well as injections? Here’s what studies show about weight loss, side effectsJune 15, 2026 (NEXSTAR) – GLP-1 drugs, which have grown incredibly popular in recent years for their ability to help people…
MMedication Read More The Liver Doc on his fight against pseudoscience, wellness myths and powerful interestsJune 10, 2026 A 14-year-old girl walks into his ward with severe liver damage. The culprit? Traditional herbal medicine sold freely…
MMedication Read More ‘Cancer Bush’ shows promise as complementary medicine to chemotherapyJune 2, 2026 A plant found across South Africa and long used in traditional medicine could one day help fight some…
MMedication Read More An experimental GLP-1 pushes the limits of weight loss. There are risks.May 30, 2026 Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity…
HHealth care Read More BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual MeetingMay 28, 2026 BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., May 27, 2026 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today…
MMedication Read More Wegovy® pill delivered 21.6% weight loss in early responders and doubled mobility improvement, according to new Novo Nordisk data at ECO2026May 14, 2026 Novo Nordisk A/S Almost a third of adults taking Wegovy® pill (oral semaglutide 25 mg) were early responders…
FFitness Read More Longevity and Strength Exercises: 6 Trainer-Approved Moves to TryMay 14, 2026 Most longevity scientists and doctors agree that one habit is better than any drug or supplement for healthy…
MMedication Read More Study reveals high use of complementary health approaches in seniorsApril 29, 2026 Researchers say the finding highlights the need for more evidence and better conversations about risks and benefits of…
MMedication Read More Veradermics hair loss pill passes late-stage clinical trialApril 28, 2026 Veradermics announced Monday that its experimental oral hair loss pill, VDPHL01, met all primary and key secondary endpoints…